Stratec stock reports Q2 recovery with an 11.9 percent EBIT margin

Published on 10/04/2026 at 12:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stratec stock traded at EUR 21.70 on October 2, 2026, after Q2 revenue rose 2.4 percent year over year. mwb research set a EUR 21.00 target and a Sell rating.

Schwarzweißfoto eines Technikers bei Mikroskoparbeit in der Gerätefertigung — Stratec SE (DE000STRA555) steht für Präzisionsfertigung, dokumentiert in dieser Schwarzweiß-Reportageaufnahme eines Technikers, Illustration mit AI erstellt.

Stratec (DE000STRA555) was last quoted at EUR 21.70 on Xetra on October 2, 2026 at 5:35 p.m. CET, up 0.23 percent from the previous day. The latest substantive signal is the company's Q2 recovery, paired with a demanding second half for 2026.

Q2 margin recovery takes shape

According to mwb research in its September 17, 2026 analysis, Q2 2026 revenue rose 2.4 percent year over year at constant currency to EUR 59.1 million. Adjusted EBIT increased 125.3 percent year over year to EUR 7.0 million, lifting the adjusted EBIT margin to 11.9 percent.

The comparison with Q2 2025 shows the operational shift: sales increased from EUR 58.2 million to EUR 59.1 million, while reported EBIT climbed from EUR 2.2 million to EUR 5.6 million. Analyzer Systems led the improvement, while Service Parts and Consumables remained the weaker part of the mix, according to mwb research.

Second half sets the test

Stratec's 2026 target requires EUR 149 million to EUR 161 million of revenue in the second half, compared with EUR 132 million in the second half of 2025. That implies second-half growth of 12 percent to 22 percent, making the final quarter the central execution test.

The risk is concentrated in demand quality rather than the Q2 margin alone. Customer ordering patterns remain volatile, recurring revenue is weak, and the recovery must extend beyond analyzer systems for the improved profitability to become durable.

Analyst view turns more cautious

FinanzNachrichten reported on September 17, 2026 that mwb research cut its rating from Hold to Sell while keeping the price target at EUR 21.00. The report tied the downgrade to the demanding second-half revenue requirement and volatile customer demand.

The broader analyst consensus remains Overweight at the September 7, 2026 snapshot published by The Wall Street Journal, based on 8 analysts. The average price target was EUR 27.17, with a high of EUR 37.00 and a low of EUR 21.00.

Stratec stock stays near EUR 22

Stratec stock was last quoted at EUR 21.70 on Xetra on October 2, 2026 at 5:35 p.m. CET. The session volume was 6,263 shares and market capitalization stood at EUR 263.2 million.